Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Kavanaugh

Showing results (21-30 of 381) with videos related to

Pageof 39
Sort By:
Clinics in Geriatric Medicine|May 25, 2005
Rheumatic disease in the elderly: rheumatoid arthritisZuhre Tutuncu, Arthur Kavanaugh
Clinics in Dermatology|September 13, 2006
Rheumatoid arthritis in dermatologyTissa Hata, Arthur Kavanaugh
Rheumatic Diseases Clinics of North America|June 3, 2004
Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatmentsJeffry Bieber, Arthur Kavanaugh
Clinical and Experimental Rheumatology|October 13, 2015
Trial design in psoriatic arthritis: what could be changed?Arthur Kavanaugh, Tristan Boyd
Expert Opinion on Therapeutic Targets|November 22, 2007
Tumor necrosis factor as a therapeutic target of rheumatologic diseaseChristoph Ackermann, Arthur Kavanaugh
Expert Review of Clinical Immunology|August 5, 2014
A review of disease activity measures for psoriatic arthritis: what is the best approach?Minyoung Her, Arthur Kavanaugh
Lancet (London, England)|August 6, 2013
Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' replyCem Gabay, Arthur Kavanaugh,
Nature Reviews. Gastroenterology & Hepatology|April 22, 2015
Advances in use of immunomodulatory agents--a rheumatology perspectiveMinyoung Her, Arthur Kavanaugh
The Journal of Rheumatology. Supplement|July 4, 2012
Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL)Arthur Kavanaugh, Philip Mease
Clinical and Experimental Rheumatology|October 20, 2012
Critical analysis of economic tools and economic measurement applied to rheumatoid arthritisMinyoung Her, Arthur Kavanaugh
Pageof 39

Showing results (21-30 of 381) with videos related to

Sort By:
Pageof 39
Clinics in Geriatric Medicine|May 25, 2005
Rheumatic disease in the elderly: rheumatoid arthritisZuhre Tutuncu, Arthur Kavanaugh
Clinics in Dermatology|September 13, 2006
Rheumatoid arthritis in dermatologyTissa Hata, Arthur Kavanaugh
Rheumatic Diseases Clinics of North America|June 3, 2004
Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatmentsJeffry Bieber, Arthur Kavanaugh
Clinical and Experimental Rheumatology|October 13, 2015
Trial design in psoriatic arthritis: what could be changed?Arthur Kavanaugh, Tristan Boyd
Expert Opinion on Therapeutic Targets|November 22, 2007
Tumor necrosis factor as a therapeutic target of rheumatologic diseaseChristoph Ackermann, Arthur Kavanaugh
Expert Review of Clinical Immunology|August 5, 2014
A review of disease activity measures for psoriatic arthritis: what is the best approach?Minyoung Her, Arthur Kavanaugh
Lancet (London, England)|August 6, 2013
Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' replyCem Gabay, Arthur Kavanaugh,
Nature Reviews. Gastroenterology & Hepatology|April 22, 2015
Advances in use of immunomodulatory agents--a rheumatology perspectiveMinyoung Her, Arthur Kavanaugh
The Journal of Rheumatology. Supplement|July 4, 2012
Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL)Arthur Kavanaugh, Philip Mease
Clinical and Experimental Rheumatology|October 20, 2012
Critical analysis of economic tools and economic measurement applied to rheumatoid arthritisMinyoung Her, Arthur Kavanaugh
Pageof 39